CONNECT WITH US
HealthTech

HealthTech

WuXi AppTec raises revenue forecast again in the face of DoD court case

Endpoints News logo

Published on

Add as a preferred source on Google
WuXi AppTec raises revenue forecast again in the face of DoD court case

WuXi AppTec rais­es rev­enue fore­cast again in the face of DoD court case

WuXi AppTec’s dis­pute with the US De­part­ment of De­fense over its des­ig­na­tion as a Chi­nese mil­i­tary com­pa­ny isn’t stand­ing in the way of its per­for­mance: …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Roche’s chang­ing plans show how MFN is com­pli­cat­ing Eu­ro­pean drug launch­es October 26, 2026

EGFR-mu­tant lung can­cer is an ADC bat­tle­ground, with Chi­na lead­ing the charge October 26, 2026

Corx­el to take oral GLP-1 pub­lic in the US via SPAC October 26, 2026

BioN­Tech, Du­al­i­ty­Bio pon­der next steps for HER2 ADC af­ter 'mod­est' breast can­cer re­sults

Mer­ck and Mod­er­na's can­cer vac­cine da­ta were 'a tri­umph of sci­ence.' And now, the work be­gins

Be­yond the can­cer vac­cine, how did Mer­ck’s on­col­o­gy pipeline do at ES­MO?

Swiss biotech Wind­ward Bio files for Nas­daq IPO to fund Chi­na-de­rived as­sets and in-house R&D



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.